Medscape Medical NewsAll articles

AutoContour (Model RADAC V4)

Radformation, Inc. • Radiology • 12/09/2024

510(k)IEC 62304 Class C
FDA Summary PDF

Device Purpose

The AutoContour (Model RADAC V4) is a Class II medical image management and processing system engineered to automate the contouring process for radiation therapy treatment planning. This device leverages machine learning to accurately delineate various organs and volumes of interest on both CT and MR images, with its performance rigorously validated through comprehensive non-clinical testing, including Dice Similarity Coefficient analysis, ensuring clinical utility.

Summary

Radformation, Inc.'s device, AutoContour (Model RADAC V4), a medical image management and processing system classified as Class II, has been determined to be substantially equivalent to a legally marketed predicate device. This software is designed to assist radiation treatment planners in automatically contouring and reviewing structures within medical images, specifically for radiation therapy treatment planning.The updated AutoContour (Model RADAC V4) expands upon its predecessor by incorporating additional organs and volumes of interest for machine-learning based contouring on both CT and MR image types. Comprehensive non-clinical verification and validation testing, including Dice Similarity Coefficient (DSC) analysis and qualitative clinical appropriateness grading by experts, confirmed that all new models met predefined performance criteria. The testing demonstrated the device's accuracy and clinical utility, supporting the conclusion that it is as safe and effective as the predicate device.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

AutoContourRadiation TherapyTreatment PlanningMedical Image ProcessingMachine LearningCT ImagingMR ImagingContouringDice Similarity CoefficientClinical Utility

Device Metadata

Submission Number
K242729
Company
Radformation, Inc.
Panel
Radiology
Product Code
N/A
Data Type
N/A
Clinical Function
N/A
AI Function
N/A
AI Subclass
N/A

Relevant Clinical Questions

  • Q1. What specific organs and volumes of interest have been added to AutoContour V4, and how does their performance compare across different anatomical sites?; Beyond Dice Similarity Coefficient (DSC) analysis, what other quantitative metrics were used to assess contouring accuracy, particularly for complex or critical structures?; How does the machine learning model adapt to variations in image quality, patient anatomy, or imaging protocols, and what are its limitations in these scenarios?; What is the long-term impact of using AutoContour V4 on clinical workflow efficiency and inter-observer variability in radiation treatment planning?; Are there plans to integrate AutoContour with adaptive radiation therapy workflows or expand its capabilities to other imaging modalities or treatment areas?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class C (software safety classification); Post-§524B but no clear network capability detected

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score10/100
SBOM Evidence⚠ Not in summary - likely in full submission per §524B
Cyber Risk Assessment⚠ Not in summary - likely in full submission per §524B
Postmarket Plan⚠ Not in summary - likely in full submission per §524B
§524B ApplicableYes

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(machine learning)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(server)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM detected in AI-generated device summary.

• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.

• Cybersecurity risk assessment not referenced in AI-generated device summary. FDA cybersecurity guidance (2023) expects this for cyber devices.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
AutoContour (Model RADAC V4) - Radformation, Inc. | ESL FDA AI Device Intelligence